DE69429753D1 - Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung - Google Patents

Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung

Info

Publication number
DE69429753D1
DE69429753D1 DE69429753T DE69429753T DE69429753D1 DE 69429753 D1 DE69429753 D1 DE 69429753D1 DE 69429753 T DE69429753 T DE 69429753T DE 69429753 T DE69429753 T DE 69429753T DE 69429753 D1 DE69429753 D1 DE 69429753D1
Authority
DE
Germany
Prior art keywords
protecting group
amino
preparation
carboxyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69429753T
Other languages
English (en)
Other versions
DE69429753T2 (de
Inventor
Jae Hong Yeo
Chan Sik Bang
Jong Chan Lim
Young Min Woo
Deog Ho Yang
Se Ho Kim
Jae Hoon Jeon
Mu Yong Kim
Sam Sik Kim
Tae Hee Lee
Yong Zu Kim
Hun Seung Oh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Corp
Original Assignee
Lucky Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lucky Ltd filed Critical Lucky Ltd
Publication of DE69429753D1 publication Critical patent/DE69429753D1/de
Application granted granted Critical
Publication of DE69429753T2 publication Critical patent/DE69429753T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69429753T 1993-09-11 1994-09-08 Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung Expired - Fee Related DE69429753T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930018321A KR100257130B1 (ko) 1993-09-11 1993-09-11 신규 세팔로스포린계 항생제 및 이의 제조방법

Publications (2)

Publication Number Publication Date
DE69429753D1 true DE69429753D1 (de) 2002-03-14
DE69429753T2 DE69429753T2 (de) 2002-08-29

Family

ID=19363395

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69429753T Expired - Fee Related DE69429753T2 (de) 1993-09-11 1994-09-08 Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung

Country Status (14)

Country Link
US (1) US5541175A (de)
EP (1) EP0643061B1 (de)
JP (1) JP2552818B2 (de)
KR (1) KR100257130B1 (de)
CN (1) CN1040109C (de)
AT (1) ATE212637T1 (de)
AU (1) AU670709B2 (de)
CA (1) CA2131769C (de)
DE (1) DE69429753T2 (de)
DK (1) DK0643061T3 (de)
ES (1) ES2170758T3 (de)
PT (1) PT643061E (de)
RU (1) RU2098420C1 (de)
TW (1) TW273553B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7427680B2 (en) * 2001-01-12 2008-09-23 The Regents Of The University Of California Fluorogenic substrates for BETA-lactamase gene expression
FR2737893B1 (fr) * 1995-08-16 1997-09-12 Roussel Uclaf Nouvelles cephalosporines comportant en position 7, un radical benzyloxyimino substitue, leur procede et intermediaires de preparation, leur application comme medicaments
JP4157177B2 (ja) * 1997-06-04 2008-09-24 大塚化学ホールディングス株式会社 ３−アルケニルセフェム化合物の製造法
KR100347608B1 (ko) * 2000-06-01 2002-08-07 삼화페인트공업주식회사 유화중합방법에 의하여 내부기공을 갖는 미세입자의제조방법
KR20020085176A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
US8883772B2 (en) 2007-10-09 2014-11-11 Sopharmia, Inc. Broad spectrum beta-lactamase inhibitors
ES2700575T3 (es) 2013-03-12 2019-02-18 Gladius Pharmaceuticals Corp 3-Estiril-cefalosporinas derivadas
CN103709164B (zh) * 2013-12-04 2016-08-24 浙江诚意药业股份有限公司 一种腺嘌呤的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202315A (en) * 1989-05-11 1993-04-13 Lucky, Ltd. Cephalosporin compounds
US5373001A (en) * 1990-06-15 1994-12-13 Roussel Uclaf Cephalosporins
FR2684995A1 (en) * 1991-12-12 1993-06-18 Roussel Uclaf Cephalosporins containing a ( alpha -carboxy-3,4-dihydroxybenzyloxyimino) group, preparation process and intermediates, application as medicaments and pharmaceutical compositions
FR2663332B1 (fr) * 1990-06-15 1997-11-07 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus.
KR930007264B1 (ko) * 1990-08-17 1993-08-04 주식회사 럭키 신규한 세팔로스포린 화합물과 그의 제조방법
US5095012A (en) * 1990-08-23 1992-03-10 Bristol-Myers Squibb Company Antibiotic c-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof
EP0508375A3 (en) * 1991-04-12 1992-12-09 Lucky Ltd. Novel cephalosporin compounds and processes for preparation thereof

Also Published As

Publication number Publication date
CN1106411A (zh) 1995-08-09
RU94032285A (ru) 1996-07-20
EP0643061A1 (de) 1995-03-15
TW273553B (de) 1996-04-01
ES2170758T3 (es) 2002-08-16
KR950008517A (ko) 1995-04-17
KR100257130B1 (ko) 2000-05-15
RU2098420C1 (ru) 1997-12-10
JPH07215876A (ja) 1995-08-15
US5541175A (en) 1996-07-30
DK0643061T3 (da) 2002-04-29
ATE212637T1 (de) 2002-02-15
JP2552818B2 (ja) 1996-11-13
PT643061E (pt) 2002-07-31
CA2131769C (en) 1999-12-28
CN1040109C (zh) 1998-10-07
AU7286394A (en) 1995-03-30
DE69429753T2 (de) 2002-08-29
AU670709B2 (en) 1996-07-25
CA2131769A1 (en) 1995-03-12
EP0643061B1 (de) 2002-01-30

Similar Documents

Publication Publication Date Title
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
ATE46696T1 (de) 1- und 1,1-disubstituierte, 6-substituierte, 2carbamimidoyl-1-carbadethiapen-2-em-3carbons|uren, verfahren zur herstellung und diese enthaltende antibiotische zusammensetzung.
JPS5569586A (en) 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
ATE172731T1 (de) Pyrazolopyridinverbindung und verfahren zu ihrer herstellung
HUT56370A (en) Process for producing tricyclic carbapenem derivatives and pharmaceutical compositions comprising such compounds as active ingredient
FI893467A0 (fi) Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
ES474288A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos
HUP9702345A2 (hu) 3-Hidroxi-piridin-2-karbonsav-amid-észter-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO975901D0 (no) Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
ATE27701T1 (de) 2-carbamimidoyl-6-substituierte-1-carbadethiape - 2-em-3-carbonsaeure, verfahren zur herstellung und sie enthaltendes antibiotisches arzneipraeparat.
ATE61340T1 (de) Aminosaeurederivate und deren verfahren zur herstellung.
HUT67259A (en) 5-amino-8-methyl-7-pyrrolidinyl-quinoline-3-carboxylic acid derivatives and pharmaceutical compositions containing them
ATE141606T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung
DE69429753D1 (de) Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung
AU1166988A (en) New peptide derivatives having a polycyclic nitrogenous structure, process for the preparation thereof and pharmaceutical compositions containing them
HUT61009A (en) Process for producing 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
AU1774188A (en) New tripeptide derivatives having a polycyclic nitrogenous structure, process of the preparation thereof and pharmaceutical compositions containing them
HU9300283D0 (en) Method for producing amino-benzoic acid derivatives and pharmaceutical preparatives containing them
ES8101646A1 (es) Un procedimiento para producir un compuesto opticamente ac- tivo
ATE97902T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DIE BEZEICHNUNG IST ZU AENDERN IN: ANTIBIOTISCH WIRKSAME CEPHALOSPORINE UND VERFAHREN ZU IHRER HERSTELLUNG

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee